High‐density‐lipoprotein cholesterol (HDL‐C) has been identified in population studies as
an independent inverse predictor of cardiovascular events. Although the causal nature of …

Low high-density lipoprotein (HDL) cholesterol levels are associated with an increased risk
of coronary artery disease and myocardial infarction. Experimental studies have identified …

This review aims to provide an overview on the properties of high‐density lipoproteins
(HDLs) and their cardioprotective effects. Emergent HDL therapies will be presented in the …

Low high-density lipoprotein (HDL) cholesterol is associated with increased risk of coronary
heart disease (CHD). Ongoing investigation into the mechanisms whereby HDL cholesterol …

High-density lipoprotein (HDL) therapy is an emerging area of therapeutic development in
the cardiovascular field, aimed at supplementing and improving the vascular benefit exerted …

The concentration of high density lipoprotein-cholesterol (HDL-C) has been found
consistently to be a powerful negative predictor of premature coronary heart disease (CHD) …

HDL-cholesterol and cardiovascular disease: rethinking our a... : Current Opinion in
Cardiology HDL-cholesterol and cardiovascular disease: rethinking our approach : Current …

Atherosclerosis is one of the most common causes of death and disability in the United
States today despite the availability of statins, which reduce hyperlipidemia, a risk factor that …

High-density lipoprotein-cholesterol (HDL-C) is a continuous inverse cardiovascular risk
factor. The mechanisms by which HDLs protect against atherosclerosis are multiple. The …

Atherosclerosis is the underlying cause of heart attack and stroke. Early observations that
cholesterol is a key component of arterial plaques gave rise to the cholesterol hypothesis for …